Gene linked to more aggressive prostate cancer

A new large-scale study appears to confirm that prostate cancer patients with mutations in the BRCA2 gene are likely to have more aggressive and rapid progression of the disease, and to have worse survival outcomes. Certain mutations in the BRCA genes are well known to be strong determinants of part ...